Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nicolò Morellato"'
Autor:
Antonio Rosato, Cristina Bolzati, Fiorenzo Refosco, Nicola Salvarese, Nicolò Morellato, Laura Meléndez-Alafort
Publikováno v:
Journal of medicinal chemistry 57 (2014): 8960–8970. doi:10.1021/jm501088w
info:cnr-pdr/source/autori:Salvarese N.; Morellato N.; Rosato A.; Melendez-Alafort L.; Refosco F.; Bolzati C./titolo:Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies/doi:10.1021%2Fjm501088w/rivista:Journal of medicinal chemistry/anno:2014/pagina_da:8960/pagina_a:8970/intervallo_pagine:8960–8970/volume:57
info:cnr-pdr/source/autori:Salvarese N.; Morellato N.; Rosato A.; Melendez-Alafort L.; Refosco F.; Bolzati C./titolo:Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies/doi:10.1021%2Fjm501088w/rivista:Journal of medicinal chemistry/anno:2014/pagina_da:8960/pagina_a:8970/intervallo_pagine:8960–8970/volume:57
A general procedure for the preparation of a new class of neutral six-coordinated mixed ligand [Tc-99m(III)(PS)(2)(Ln)] compounds (PS = trisalkyl-phosphino-thiolate; Ln = dithiocarbamate) is reported as well as their in vitro stability and the ex viv
Autor:
Alfonso Venzo, Fiorenzo Refosco, Nicola Salvarese, Nicolò Morellato, Cristina Bolzati, Alessandro Dolmella
Publikováno v:
Inorganic chemistry (Online) 52 (2013): 6365–6377. doi:10.1021/ic400094s
info:cnr-pdr/source/autori:Salvarese N.; Morellato N.; Venzo A.; Refosco F.; Dolmella A.; Bolzati C./titolo:Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy/doi:10.1021%2Fic400094s/rivista:Inorganic chemistry (Online)/anno:2013/pagina_da:6365/pagina_a:6377/intervallo_pagine:6365–6377/volume:52
info:cnr-pdr/source/autori:Salvarese N.; Morellato N.; Venzo A.; Refosco F.; Dolmella A.; Bolzati C./titolo:Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy/doi:10.1021%2Fic400094s/rivista:Inorganic chemistry (Online)/anno:2013/pagina_da:6365/pagina_a:6377/intervallo_pagine:6365–6377/volume:52
The synthesis and characterization of a new series of neutral, six-coordinated mixed-ligand compounds [M(III)(PS)2(L)] (M = Re; (99)Tc), where PS is bis(arylalkyl)- or trialkylphosphinothiolate and L is dithiocarbamate, are reported. Stable [M(III)(P
Autor:
Davide, Carta, Nicola, Salvarese, Nicolò, Morellato, Feng, Gao, Wiebke, Sihver, Hans Jurgen, Pietzsch, Barbara, Biondi, Paolo, Ruzza, Fiorenzo, Refosco, Debora, Carpanese, Antonio, Rosato, Cristina, Bolzati
Publikováno v:
Nuclear medicine and biology. 43(12)
The purpose of this study was to evaluate the effect of cyclization on the biological profile of a [
Autor:
H.-J. Pietzsch, Barbara Biondi, Antonio Rosato, Wiebke Sihver, Feng Gao, Nicola Salvarese, Cristina Bolzati, Davide Carta, Nicolò Morellato, Fiorenzo Refosco, Paolo Ruzza, Debora Carpanese
Publikováno v:
Nuclear Medicine and Biology 43(2016)12, 788-801
Nuclear medicine and biology 43 (2016): 788–801. doi:10.1016/j.nucmedbio.2016.08.014
info:cnr-pdr/source/autori:Carta D.; Salvarese N.; Morellato N.; Gao F.; Sihver W.; Pietzsch H.J.; Biondi B.; Ruzza P.; Refosco F.; Carpanese D.; Rosato A.; Bolzati C./titolo:Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties/doi:10.1016%2Fj.nucmedbio.2016.08.014/rivista:Nuclear medicine and biology/anno:2016/pagina_da:788/pagina_a:801/intervallo_pagine:788–801/volume:43
Nuclear medicine and biology 43 (2016): 788–801. doi:10.1016/j.nucmedbio.2016.08.014
info:cnr-pdr/source/autori:Carta D.; Salvarese N.; Morellato N.; Gao F.; Sihver W.; Pietzsch H.J.; Biondi B.; Ruzza P.; Refosco F.; Carpanese D.; Rosato A.; Bolzati C./titolo:Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties/doi:10.1016%2Fj.nucmedbio.2016.08.014/rivista:Nuclear medicine and biology/anno:2016/pagina_da:788/pagina_a:801/intervallo_pagine:788–801/volume:43
The purpose of this study was to evaluate the effect of cyclization on the biological profile of a [ 99m Tc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analog. A lactam bridge-cyclized H-Cys-Ahx-βAla 3 -c[Lys 4 -Glu-His-D-Phe-Arg-Trp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3677dfefd831e434bdfe15df2be3413e
https://www.hzdr.de/publications/Publ-24162-1
https://www.hzdr.de/publications/Publ-24162-1
Autor:
Nicolò Morellato, Caterina Musetti, Cristina Bolzati, Manlio Palumbo, Alessandro Dolmella, Claudia Sissi
Publikováno v:
Inorganica Chimica Acta (Testo stamp.) 434 (2015): 127–134. doi:10.1016/j.ica.2015.04.037
info:cnr-pdr/source/autori:Morellato N.; Musetti C.; Palumbo M.; Dolmella A.; Bolzati C.; Sissi C./titolo:Biologically relevant Cu2+ complexes with a tridentate phenanthroline analogue: Structural properties and DNA damage/doi:10.1016%2Fj.ica.2015.04.037/rivista:Inorganica Chimica Acta (Testo stamp.)/anno:2015/pagina_da:127/pagina_a:134/intervallo_pagine:127–134/volume:434
info:cnr-pdr/source/autori:Morellato N.; Musetti C.; Palumbo M.; Dolmella A.; Bolzati C.; Sissi C./titolo:Biologically relevant Cu2+ complexes with a tridentate phenanthroline analogue: Structural properties and DNA damage/doi:10.1016%2Fj.ica.2015.04.037/rivista:Inorganica Chimica Acta (Testo stamp.)/anno:2015/pagina_da:127/pagina_a:134/intervallo_pagine:127–134/volume:434
Cu2+ coordination by a tridentate phenanthroline-related derivative (P120) was examined and compared to phenanthroline. Results from X-ray analysis underlined significant increments in the N-Cu bond lengths in Cu(P120)(H2O)SO4 which are counterbalanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092a3d2fbd4c62a77744bebf42c1cc53
https://publications.cnr.it/doc/334323
https://publications.cnr.it/doc/334323
Autor:
Nicolò Morellato, Stefan Thieme, Davide Carta, Paolo Ruzza, Cristina Bolzati, Christian Jentschel, Hans-Jürgen Pietzsch, Fiorenzo Refosco, Nicola Salvarese, Ralf Bergmann
Publikováno v:
Nuclear medicine and biology 41 (2014): 570–581. doi:10.1016/j.nucmedbio.2014.04.126
info:cnr-pdr/source/autori:Carta D.; Jentschel C.; Thieme S.; Salvarese N.; Morellato N.; Refosco F.; Ruzza P.; Bergmann R.; Pietzsch H.-J.; Bolzati C./titolo:Assessment of the best N3-donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ)/doi:10.1016%2Fj.nucmedbio.2014.04.126/rivista:Nuclear medicine and biology/anno:2014/pagina_da:570/pagina_a:581/intervallo_pagine:570–581/volume:41
info:cnr-pdr/source/autori:Carta D.; Jentschel C.; Thieme S.; Salvarese N.; Morellato N.; Refosco F.; Ruzza P.; Bergmann R.; Pietzsch H.-J.; Bolzati C./titolo:Assessment of the best N3-donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ)/doi:10.1016%2Fj.nucmedbio.2014.04.126/rivista:Nuclear medicine and biology/anno:2014/pagina_da:570/pagina_a:581/intervallo_pagine:570–581/volume:41
Succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ) are nitrido nitrogen atom donors employed for the preparation of nitride [M(N)]-complexes (M=(99m)Tc and (188)Re)
Autor:
Nicolò Morellato, Nicola Salvarese, Christine Marzano, Valentina Gandin, Gianfranco Cicoria, Cristina Bolzati, C. Malizia
Owing to its suitable decay properties, Ce [T1⁄2= 32.5 d to Pr (stable), Eβ(max)= 434 keV (70%), 580 keV (30%), Eγ = 145 keV (48.5%)] could be envisaged as a promising radionuclide for developing theranostic agents for metastatic bone tumor. Ceri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c30fc4686590739c517311987d5f09
http://hdl.handle.net/11577/3035308
http://hdl.handle.net/11577/3035308
Autor:
Fiorenzo Refosco, Antonio Rosato, Alessandro Dolmella, Nicolò Morellato, Nicola Salvarese, Debora Carpanese, Laura Meléndez-Alafort, Cristina Bolzati
Publikováno v:
Nuclear medicine and biology 41 (2014): 625–625. doi:10.1016/j.nucmedbio.2014.05.030
info:cnr-pdr/source/autori:Salvarese, N.; Morellato, N.; Dolmella, A.; Melendez-Alafort, L.; Carpanese, D.; Rosato, A.; Refosco, F.; Bolzati, C./titolo:Tc-III-based mixed complexes for the design and the development of new SPECT tracers/doi:10.1016%2Fj.nucmedbio.2014.05.030/rivista:Nuclear medicine and biology/anno:2014/pagina_da:625/pagina_a:625/intervallo_pagine:625–625/volume:41
info:cnr-pdr/source/autori:Salvarese, N.; Morellato, N.; Dolmella, A.; Melendez-Alafort, L.; Carpanese, D.; Rosato, A.; Refosco, F.; Bolzati, C./titolo:Tc-III-based mixed complexes for the design and the development of new SPECT tracers/doi:10.1016%2Fj.nucmedbio.2014.05.030/rivista:Nuclear medicine and biology/anno:2014/pagina_da:625/pagina_a:625/intervallo_pagine:625–625/volume:41
The trivalent state is the most stable oxidation state of technetium and rhenium, however, none of the radiopharmaceuticals currently in clinical use contains the metal in this oxidation state. We present here a general procedure for the preparation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f83003b3115f18812dacd70178436de1
http://www.cnr.it/prodotto/i/317981
http://www.cnr.it/prodotto/i/317981
Autor:
Nicola Antonio Colabufo, Cristina Bolzati, Mariangela Cantore, Davide Carta, Valentina Gandin, Nicolò Morellato, Nicola Salvarese, Cristina Marzano
Publikováno v:
JBIC. Journal of biological inorganic chemistry
18 (2013): 523–538. doi:10.1007/s00775-013-0997-1
info:cnr-pdr/source/autori:Bolzati C.; Carta D.; Gandin V.; Marzano C.; Morellato N.; Salvarese N.; Cantore M.; Colabufo N.A/titolo:99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study/doi:10.1007%2Fs00775-013-0997-1/rivista:JBIC. Journal of biological inorganic chemistry (Print)/anno:2013/pagina_da:523/pagina_a:538/intervallo_pagine:523–538/volume:18
18 (2013): 523–538. doi:10.1007/s00775-013-0997-1
info:cnr-pdr/source/autori:Bolzati C.; Carta D.; Gandin V.; Marzano C.; Morellato N.; Salvarese N.; Cantore M.; Colabufo N.A/titolo:99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study/doi:10.1007%2Fs00775-013-0997-1/rivista:JBIC. Journal of biological inorganic chemistry (Print)/anno:2013/pagina_da:523/pagina_a:538/intervallo_pagine:523–538/volume:18
[(99m)Tc(N)(DBODC)(PNP5)](+) [DBODC is bis(N-ethoxyethyl)dithiocarbamato; PNP5 is bis(dimethoxypropylphosphinoethyl)ethoxyethylamine], abbreviated as (99m)Tc(N)-DBODC(5), is a lipophilic cationic mixed compound investigated as a myocardial imaging ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3621216ec4304eb189ff3143e08c18d
http://hdl.handle.net/11577/2620644
http://hdl.handle.net/11577/2620644